No abstract available
MeSH terms
-
Clinical Trials, Phase III as Topic*
-
Humans
-
Hypercholesterolemia / diagnosis*
-
Hypercholesterolemia / prevention & control*
-
Hypolipidemic Agents / adverse effects*
-
Hypolipidemic Agents / therapeutic use*
-
Proprotein Convertase 9
-
Proprotein Convertases / antagonists & inhibitors*
-
Serine Endopeptidases
-
Treatment Outcome
Substances
-
Hypolipidemic Agents
-
PCSK9 protein, human
-
Proprotein Convertase 9
-
Proprotein Convertases
-
Serine Endopeptidases